0.87% of Artelo Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Artelo Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/17/2021	Virtu Financial LLC	22,594	$27K	0.0%	-85.3%	0.092%
8/13/2021	Renaissance Technologies LLC	556,738	$0.66M	0.0%	N/A	2.273%
8/13/2021	Vanguard Group Inc.	862,172	$1.03M	0.0%	+247.5%	3.520%
8/12/2021	Penserra Capital Management LLC	28,427	$27K	0.0%	N/A	0.116%
8/11/2021	Bank of New York Mellon Corp	86,603	$0.10M	0.0%	-15.4%	0.354%
8/6/2021	HighTower Advisors LLC	62,000	$74K	0.0%	N/A	0.253%
5/19/2021	Virtu Financial LLC	153,769	$0.25M	0.0%	N/A	0.664%
5/18/2021	Citadel Advisors LLC	180,814	$0.30M	0.0%	N/A	0.781%
5/18/2021	Jane Street Group LLC	21,108	$34K	0.0%	N/A	0.091%
5/13/2021	Kepos Capital LP	200,000	$0.33M	0.0%	-20.0%	0.864%
5/13/2021	Bank of New York Mellon Corp	102,390	$0.17M	0.0%	N/A	0.442%
5/12/2021	Geode Capital Management LLC	141,273	$0.23M	0.0%	+132.1%	0.610%
5/12/2021	UBS Group AG	15,675	$26K	0.0%	N/A	0.068%
4/6/2021	LVM Capital Management Ltd. MI	20,000	$33K	0.0%	N/A	0.127%

Data available starting January 2016

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Today's Range

Now: $1.34

$1.28

$1.34

50 Day Range

MA: $1.50

$1.28

$1.73

52 Week Range

Now: $1.34

$1.15

$2.98

Volume

5,411 shs

Average Volume

15,800 shs

Market Capitalization

$4.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.45

Who are the company insiders with the largest holdings of Artelo Biosciences?: Artelo Biosciences' top insider shareholders include:
Gregory D Gorgas (CEO)
Learn More about top insider investors at Artelo Biosciences.